Indian Immunologicals Limited (IIL) rejected Australian advisory warning of counterfeit Abhayrab rabies vaccines, calling it outdated and over-cautious. IIL insists only one batch was affected in January 2025 and is no longer in circulation. Meanwhile, Australian authorities maintain travellers should replace doses, leaving patients caught between conflicting guidance.